Lillys revenue hit $17.60 billion, beating estimates by 9.5%, with Mounjaro generating $6.52 billion (up 109%) and Zepbound adding $3.57 billion (up 184%)

Given its high usage and availability as an over-the-counter analgesic, a systematic review of paracetamols efficacy and tolerability in individual conditions is warranted ( On the whole, although there is no direct evidence in COVID-19 patients, PAC is likely to promote GSH depletion, especially in those population groups at higher risk ( The following considerations further strengthen the criticism toward the use of PAC as a safer alternative to NSAID: PAC has been preferred to NSAIDs and steroids for the symptomatic and domiciliary management of the early stages of COVID-19, a choice grounded of the precautionary principle (but still theoretical in this specific case) principle primum non nocere ( Counterintuitively, however, the same precautionary principle has not been applied to PAC itself, and the risks of developing severe COVID-19 associated to the reduction of GSH might be far higher than the benefits derived from discouraging the use of NSAIDs or steroids

This shift is designed to help provide patients with medications that have gained full approval, assuring safety and efficacy
Correlation between MASH resolution and improvement in features of the metabolic syndrome Changes in features of the metabolic syndrome at week 72 are presented by treatment and MASH resolution response at week 72 using descriptive statistics based on the on-treatment observation period
PMID 14596823
The study was done in Turkey, where the lead levels in the air are so high that all of that extra breathing by the athletes evidently made things worse, which I think underscores an important point